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Keratoacanthoma centrifugum marginatum (KCM) is a rare variant of keratoacanthoma and is charac-
terized by progressive peripheral growth with accompanying central healing. Here, we report a case of
multiple KCM. A 53-year-old man presented with multiple erythematous papulonodules on both upper
limbs and neck for >2 years. His skin lesions enlarged in an annular manner with central residual cri-
briform scarring that eventually formed conﬂuent plaques (2e8 cm in diameter) with elevated hyper-
keratotic borders. Skin biopsy of a developed matured nodule on the right forearm was consistent with
that of classical keratoacanthoma. KCM was diagnosed on the basis of clinical and pathological pre-
sentation. Low-dose acitretin (0.7 mg/kg/day) was administered and the skin lesions improved sig-
niﬁcantly within 3 months after the treatment. In this case, we present the clinical and histological
features of KCM and discuss the different effective treatment modalities.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Keratoacanthoma centrifugum marginatum (KCM) is a rare variant
of keratoacanthoma (KA) and is characterized by multiple KAs with
progressive peripheral growth and simultaneous central healing.
KCM was ﬁrst described by Miedzinski and Kozakiewicz in 1962
and the name was coined by Belisario in 1965.1 The cause of mul-
tiple KAs is unknown. Heredity, viruses, chemicals, and sunlight are
thought to be involved in the etiology of KCM.2 To date, only about
40 cases have been reported worldwide.3 Here, we report a char-
acteristic multiple KCM patient who improved signiﬁcantly after
oral acitretin treatment.Case report
A 53-year-old male patient with a 3-year history of diabetes mel-
litus under good glycemic control presented with multiple eryth-
ematous papuloplaques on both upper limbs, which had been
present for >2 years (Figure 1A). These skin lesions subsequentlyy have no ﬁnancial or non-
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).
iwanese Dermatological Associatioextended to the neck, face, upper back, and chest (Figure 1B). The
lesions progressed in an annular manner with papulonodular hy-
perkeratotic borders and development of atrophic scars at the
center (Figure 1C). The lesions were asymptomatic and ranged from
2 to 8 cm in diameter. The patient did not have any family history of
similar lesions; he had not been administered any drugs, nor had he
been exposed to any chemicals. Histopathological examination of
a developed matured nodule on the right forearm indicated epi-
dermal hyperplasia (pseudoepitheliomatous hyperplasia) with
central crater-like hyperkeratosis (Figure 2). The keratinocytes had
enlarged nuclei with glassy cytoplasm without hyperchromatism
or atypia. Intraepidermal neutrophilic microabscesses were also
observed. The dermis was inﬁltrated with mononuclear inﬂam-
matory cells. Laboratory examinations, including complete blood
count, and renal and liver function tests were normal. The assay
ﬁndings of antinuclear antibody, anti-U1 ribonucleoprotein and
anti-Smith antibody were also negative. KCMwas diagnosed on the
basis of the patient’s characteristic clinical and pathological pre-
sentation. Oral acitretin was administered at a dose of 0.7 mg/kg/
day. The skin lesions stopped progressing (i.e., no new lesion
developed and existing lesions did not extend peripherally) within
a month and showed regression indicated by ﬂattening at the
border within 3 months (Figure 3A and B). Acitretin dosage was
subsequently tapered to 0.5 mg/kg/day for maintenance of treat-
ment. The patient tolerated the treatment well without any appa-
rent adverse effects. No new or recurrent lesions were noted at 6n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Multiple annular plaques on the upper limbs. (B) Multiple annular erythematous plaques on the trunk and neck. (C) Central cribriform atrophic scar with pap-
ulonodular hyperkeratotic borders.
C.S. Sung et al. / Dermatologica Sinica 32 (2014) 25e2826months follow-up, except some skin lesions improved with hypo-
pigmented patches.Discussion
KA is a common skin tumor characterized by a dome-shaped
nodule with a central crater-like keratin plug.4 This lesion is usu-
ally solitary and tends to resolve spontaneously. KCM is a rare
variant of KA that is characterized by progressive peripheral
growth. The lesions are variable in size, ranging from 2 to 40 cm in
diameter and they frequently involve the extremities, face, neck,
and rarely, the trunk1e3,5e27 (Table 1). KCM usually does not un-
dergo spontaneous remission. KCM can be distinguished from other
subtypes of KA. KCM extends in an annular, circular, or polycyclic
manner rather than a bulk tumor as observed in giant KA (diameter,
>40 cm). Multiple KAs such as FergusoneSmith-type KAs,Figure 2 The pathology resembles the classic keratoacanthoma dome-shaped nodular
lesion with central crater-like hyperkeratosis (hematoxylin & eosin, original magniﬁ-
cation 20).Grzybowski-type KAs, Witten and Zak-type KAs and those asso-
ciated with MuireTorre syndrome are smaller and also do not
expand peripherally.
Multiple lesions of KCM are infrequently encountered and only
10 cases have been reported. Most cases have reported the
involvement of the extremities, especially the distal part, and there
is only one case each reported on the scalp, face, and neck (Table 1).
Most of the previous KCM cases have reported <20 lesions. How-
ever, our patient had>30 lesions and some lesions were present on
the face, neck, chest, and back. Compared to other reported cases,
our patient suffered from more extensive and severe skin lesions;
therefore, long-term treatment was required.
Our patient’s lesions expanded in an annular manner, therefore,
the differential diagnosis included some dermatoses with an
annular character such as tinea, granuloma annulare, leprosy, ery-
thema annulare centrifugum, and lupus erythematosus (LE). Tinea
expands with active scaly borders and usually does not leave
scarring of the central area. Granuloma annulare presents with an
annular or arcuate plaque, whose central area may present viola-
ceous or pigmented change but does not leave central healing or
keratosis. Tuberculoid or borderline leprosy shows solitary or a few
plaques; often assuming an annular conﬁguration secondary to
peripheral propagation and central clearing. Lepromatous leprosy
often presents diffused ill-deﬁned hypopigmented or hyperpig-
mented plaques or patches. The histopathology did not present
granuloma formation or necrobiosis. This ﬁnding is not consistent
with the diagnosis of granuloma annulare and tuberculoid leprosy.
Erythema annulare centrifugum expands rapidly with an annular
erythematous ring and central clearing. The central clearing and
rapid disease course are differentiated from KCM. LE, especially the
subacute type, often presents as an annular papulosquamous lesion
in the photo-distribution area. Therefore, it was considered in our
differential diagnosis. However, LE lesions do not expand periph-
erally in an annular manner and do not present with a peripheral
nodular border with central depressed scaring. Moreover, LE is
often accompanied with other systemic symptoms that did not
appear in KCM. The laboratory examinations for LE surveys were all
within the normal range. The pathology did not support this
diagnosis either. Hence, KCM was the favored diagnosis according
to the clinical and histopathological presentation.
Figure 3 (A) Pretreatment lesions: annular plaques with papulonodular hyperkeratotic borders and central atrophic scarring. (B) Skin lesions after 3 months of treatment: the
borders of the skin lesions showed ﬂattening.
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tendency for spontaneous resolution in KCM. Spontaneous reso-
lution can occur, but more cases progress continuously for years.
Some have been associated with considerable tissue destruction.4
Therefore, some authors believe that this tumor actually is a low-
grade squamous cell carcinoma and some recurrence but not me-
tastases has been described.24 As a result, active treatment was
suggested for almost all reported cases. However, therapy for KCM
can be challenging. Numerous effective treatments have been
described, including surgical excision,2 Mohs micrographic surgery,
topical and intralesional 5-ﬂuorouracil,1,2 topical imiquimod
cream,5 oral etretinate,6 oral methotrexate,7 oral retinoids,8 intra-
lesional bleomycin,9 local radiotherapy,3 photodynamic therapy,10
and systemic erlotinib.11 No consensus treatment regimens have
been established. Oral retinoids (acitretin, etretinate, or isotreti-
noin) for multiple KA have been the treatment of choice of severalTable 1 List of patients reported with keratoacanthoma centrifugum marginatum.
Author Age/sex Country Location
Borkhatariya et al 201112 65/M India Leg
Khaled et al 201013 48/M Tunisia Leg
Bulj et al 201011 74/F USA Scalp
Souza et al 200910 58/F Brazil Arm
Aroni et al 20075 45/F Greek Leg
V’lckova-Laskoska et al 20083 63/M Macedonia Hand
Aydin et al 20078 46/M Turkey Hand
Aguiar et al 200714 60/M Brazil Buttocks
Gönül et al 200615 45/M Turkey Hand
Attili et al 200616 65/F India Forearm
Yuge et al 20061 87/F Brazil Leg
Kurschat 200517 58/F Germany Eyelid
Allison et al 20042 78/F USA Extremities
Mangas et al 20047 21/M Spain Leg
Buttocks
Kato et al 200318 37/F Japan Neck
Ogasawara et al 20036 48/M Japan Extremities
Cherif et al 200219 63/M French Lower extre
Watanabe et al 199920 d Japan Hand
de la Torre et al 19979 67/F Spain Leg
Lo Schiavo et al 199621 65/F French Leg
Schaller et al 199622 78/M Germany d
Rastogi et al 199523 38/M India Lower extre
Benest et al 199424 d USA d
Chaffai et al 199425 d French d
Poiares Baptista et al 198426 d Portugal Forearm
Weedon et al 197527 d d d
d ¼ lack of data; 5-FU ¼ 5-ﬂuorouracil; F ¼ female; M ¼ male; m ¼ multiple; s ¼ singlauthors.2,8 A relatively high dose (1e3 mg/kg/day) is required in
most cases,2 however, side effects such as elevated triglyceride
levels, mucocutaneous reactions, and hyperostotic axial skeletal
changes often limit their use. In our experience, low-dose acitretin
(0.5e0.7 mg/kg/day) seems to be an effective treatment because it
has minimal side effects and can be used for a longer duration. It
has been suggested that treatment of KCM should be continued
until complete remission of skin lesions2,8; andwe also recommend
reducing the dosage of acitretin according to the clinical condition.
This modiﬁcation is expected to result in fewer side effects with
long-term use.
KCM is an uncommon variant of KA and extremely rare in Han
people. No cases have previously been reported in Taiwan (Table 1).
Moreover, our patient had typical but more extensive skin lesions
than those described in previous reports. Low-dose acitretin is an
effective treatment for KCM in our experience and we suggest thatNo. Size Treatment
s 7  3 cm Surgery
m 5e20 cm Tretinoin 0.1% cream
s d Erlotinib
s 15  12 cm Photodynamic therapy
m Imiquimod cream
s 7.5 cm Radiotherapy
m d Acitretin (0.7 mg/kg)
s 40 cm d
s 10  10 cm d
s 8  5 cm Electrodesiccation/curettage þ MTX
s 20  30 cm Topical 5% 5-FU
s d Surgery
m 13e20 cm Isotretinoin 60 mg/d þ MTX þ 5-FU
m 2e8 cm MTX þ prednisolone
s 5  2.5 cm Etretinate (0.5 mg/kg)
m d Etretinate (30 mg/d)
mity m d Acitretin (1 mg/kg/d)
s d d
s 7 cm Bleomycin (0.5 mg/mL)
s d Etretinate (1 mg/kg/d)
s d Isotretinoin (1 mg/kg/d)
mity m 2e4 cm d
d d Mohs surgery
d d Etretinate (1 mg/kg/d)
m 10  12 cm Topical 5-FU
d 20  14 cm Surgery
e.
C.S. Sung et al. / Dermatologica Sinica 32 (2014) 25e2828it should be administered until complete clinical resolution is
observed. If the skin lesions show steady improvement, we suggest
reducing acitretin dosage according to the patient’s condition in
order to prevent side effects. A regular laboratory survey should be
commenced to evaluate the possible side effects of long-term aci-
tretin use.
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